Cargando…

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey

BACKGROUND: The spread of Coronavirus disease-19 (COVID-19) poses unique challenges in the management of people with multiple sclerosis (PwMS). OBJECTIVES: To collect data about the impact of COVID-19 emergency on access to care for PwMS and on MS treatment practices. METHODS: Between March and July...

Descripción completa

Detalles Bibliográficos
Autores principales:	Portaccio, Emilio, Fonderico, Mattia, Hemmer, Bernhard, Derfuss, Tobias, Stankoff, Bruno, Selmaj, Krzysztof, Tintorè, Mar, Amato, Maria Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689421/ https://www.ncbi.nlm.nih.gov/pubmed/33764197 http://dx.doi.org/10.1177/13524585211005339

Ejemplares similares

Aggressive multiple sclerosis (2): Treatment
por: Arrambide, Georgina, et al.
Publicado: (2020)

Aggressive multiple sclerosis (1): Towards a definition of the phenotype
por: Iacobaeus, Ellen, et al.
Publicado: (2020)

Cognitive Issues in Pediatric Multiple Sclerosis
por: Portaccio, Emilio, et al.
Publicado: (2021)

Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and Prognosis
por: Fonderico, Mattia, et al.
Publicado: (2021)

Demyelination in multiple sclerosis
por: Lubetzki, Catherine, et al.
Publicado: (2014)

Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors
por: Amato, Maria Pia, et al.
Publicado: (2019)

Correction: Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors
por: Amato, Maria Pia, et al.
Publicado: (2019)

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis
por: Portaccio, Emilio, et al.
Publicado: (2021)

Personalized medicine in multiple sclerosis: hope or reality?
por: Derfuss, Tobias
Publicado: (2012)

Multiple sclerosis in the Middle East and North Africa region
por: Khoury, Samia J, et al.
Publicado: (2020)

Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis
por: Portaccio, Emilio
Publicado: (2011)

Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
por: De Stefano, Nicola, et al.
Publicado: (2016)

Impact of Diminished Expression of circRNA on Multiple Sclerosis Pathomechanisms
por: Mycko, Marcin P., et al.
Publicado: (2022)

Relevance of Brain Lesion Location to Cognition in Relapsing Multiple Sclerosis
por: Rossi, Francesca, et al.
Publicado: (2012)

B Cells and Autoantibodies in Multiple Sclerosis
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Women's Health in Multiple Sclerosis: A Scoping Review
por: Ross, Lindsay, et al.
Publicado: (2022)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Improving the Characterization of Radiologically Isolated Syndrome Suggestive of Multiple Sclerosis
por: De Stefano, Nicola, et al.
Publicado: (2011)

Update on immunopathogenesis and immunotherapy in multiple sclerosis
por: Selter, Rebecca C, et al.
Publicado: (2013)

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
por: Otero-Romero, Susana, et al.
Publicado: (2023)

Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial
por: Hemmer, Bernhard, et al.
Publicado: (2023)

Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey
por: Hadjimichael, Olympia, et al.
Publicado: (2008)

Multiple Sclerosis: circRNA Profile Defined Reveals Links to B-Cell Function
por: Zurawska, Anna E., et al.
Publicado: (2021)

Increased CD8(+) T cell responses to apoptotic T cell-associated antigens in multiple sclerosis
por: Lolli, Francesco, et al.
Publicado: (2013)

Optimizing treatment success in multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis
por: Filippi, Massimo, et al.
Publicado: (2021)

New immunopathologic insights into multiple sclerosis
por: Hemmer, Bernhard, et al.
Publicado: (2003)

PARP-1 deregulation in multiple sclerosis
por: Meira, Maria, et al.
Publicado: (2019)

The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis
por: Diebold, Martin, et al.
Publicado: (2019)

Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis
por: Grudziecka Pyrek, Monika, et al.
Publicado: (2022)

Fine Particulate Matter Related to Multiple Sclerosis Relapse in Young Patients
por: Januel, Edouard, et al.
Publicado: (2021)

Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability
por: Giorgio, Antonio, et al.
Publicado: (2017)

Association of pregnancies with risk of multiple sclerosis
por: Gasperi, Christiane, et al.
Publicado: (2022)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
por: Bodini, Benedetta, et al.
Publicado: (2016)

A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients
por: Niccolai, Claudia, et al.
Publicado: (2015)

Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation
por: Voigt, David, et al.
Publicado: (2017)

Vaccination frequency in people newly diagnosed with multiple sclerosis
por: Darvishi, Sonia, et al.
Publicado: (2023)

Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study
por: Iaffaldano, Pietro, et al.
Publicado: (2012)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
por: Castrop, Florian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v6amhvolb34u719g7hr9dmu9se